As geopolitical uncertainties persist, the possibility of a Canadian-made version of one of the most popular drugs in the ...

Kelly Grant and Chris Hannay answered reader questions on the rise of Ozempic and similar drugs in Canada, what experts are ...

Generic Ozempic is set to emerge in major markets from India and Brazil to China and Canada this year, reshaping the sector in those countries.

The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.

The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and weight-loss molecule, leading to what ...

Dr Reddy's Laboratories is set to launch its generic semaglutide injection, Obeda, in India this March, as patent protection expires in 2026.

Aspen Pharmacare's unbranded version ‌of Novo Nordisk's popular ‌diabetes drug Ozempic could be ​registered in Canada in the second or third quarter of this year, the ‌South African ⁠pharmacueticals ...

If you're considering the med for weight loss, read this first.

Public spending on prescription medications in Canada grew by more than 9 per cent in 2024, with one drug driving the ...

With the patent on Semaglutide expiring, Indian pharma companies including Dr Reddy’s, Natco, Sun Pharma, and Zydus are launching generic versions of Ozempic and similar drugs, expected to reduce ...

Novo Nordisk A/S got a warning letter from the US Food and Drug Administration for not reporting all suspected side effects ...

By Nqobile Dludla JOHANNESBURG, March 3 (Reuters) - Aspen Pharmacare's unbranded version of Novo Nordisk's popular diabetes ...